Vijay Horhey

Doctor of Osteopathic Medicine,  Charité - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Journal Manuscript Pharma-CRO-Device Data Science-Bioinformatics Case Consulting

Areas Of Interest

Development, Program Mortality, Premature Junonia coenia densovirus Surgical Incision Thrombocythemias, Idiopathic Periodontitis, Apical, Suppurative p16INK4A Protein Myelogenous Leukemia, Chronic Hydrocodone Paired Box Protein Pax 2 Residencies, Medical Computing, Cloud Bicyclo Compounds, Bridged Contracts National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division Nerve Transections, Oculomotor Carya Dehydrogenase, 1-Pyrroline-5-Carboxylate Cornifins Cavus Deformities MJ-9022-1 Cardiac Valve Annular Reduction

Professional Narrative

Dr. Vijay Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 1987
Executive Director, Amgen 2008

Education

Master of Science in physician assistant, Perelman School of Medicine 2006
Director Medicine, Perelman School of Medicine 2004

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :